PL2001900T3 - Nowe wyizolowane i oczyszczone szczepy wirusa Chikungunya i sekwencje polinukleotydów i polipeptydów oraz ich zastosowania diagnostyczne i immunogeniczne - Google Patents

Nowe wyizolowane i oczyszczone szczepy wirusa Chikungunya i sekwencje polinukleotydów i polipeptydów oraz ich zastosowania diagnostyczne i immunogeniczne

Info

Publication number
PL2001900T3
PL2001900T3 PL07734896T PL07734896T PL2001900T3 PL 2001900 T3 PL2001900 T3 PL 2001900T3 PL 07734896 T PL07734896 T PL 07734896T PL 07734896 T PL07734896 T PL 07734896T PL 2001900 T3 PL2001900 T3 PL 2001900T3
Authority
PL
Poland
Prior art keywords
polynucleotides
polypeptides
diagnostic
sequences
chikungunya virus
Prior art date
Application number
PL07734896T
Other languages
English (en)
Polish (pl)
Inventor
Philippe Despres
Anne-Claire Brehin
Valérie Marechal
Pierre Charneau
Philippe Souque
Original Assignee
Pasteur Institut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CA002538898A external-priority patent/CA2538898A1/fr
Application filed by Pasteur Institut filed Critical Pasteur Institut
Publication of PL2001900T3 publication Critical patent/PL2001900T3/pl

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/116—Togaviridae (F); Matonaviridae (F); Flaviviridae (F)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/36011—Togaviridae
    • C12N2770/36111—Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki
    • C12N2770/36121—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/36011—Togaviridae
    • C12N2770/36111—Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki
    • C12N2770/36122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/36011—Togaviridae
    • C12N2770/36111—Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki
    • C12N2770/36131—Uses of virus other than therapeutic or vaccine, e.g. disinfectant
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/18—Togaviridae; Flaviviridae
    • G01N2333/181—Alphaviruses or Group A arboviruses, e.g. sindbis, VEE, EEE, WEE or semliki forest virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
PL07734896T 2006-03-15 2007-03-15 Nowe wyizolowane i oczyszczone szczepy wirusa Chikungunya i sekwencje polinukleotydów i polipeptydów oraz ich zastosowania diagnostyczne i immunogeniczne PL2001900T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CA002538898A CA2538898A1 (fr) 2006-03-15 2006-03-15 Nouvelles souches isolees et purifiees du virus chikungunya et sequences nucleotidiques et peptidiques, applications diagnostiques et immunogeniques
CA 2545597 CA2545597A1 (en) 2006-03-15 2006-04-04 Novel isolated and purified strains of chikungunya virus and polynucleotides and polypeptides sequences, diagnostic and immunogenical uses thereof
EP07734896.9A EP2001900B1 (en) 2006-03-15 2007-03-15 Novel isolated and purified strains of chikungunya virus and polynucleotides and polypeptides sequences, diagnostic and immunogenical uses thereof
PCT/IB2007/001716 WO2007105111A2 (en) 2006-03-15 2007-03-15 Novel isolated and purified strains of chikungunya virus and polynucleotides and polypeptides sequences, diagnostic and immunogenical uses thereof

Publications (1)

Publication Number Publication Date
PL2001900T3 true PL2001900T3 (pl) 2015-10-30

Family

ID=38481184

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07734896T PL2001900T3 (pl) 2006-03-15 2007-03-15 Nowe wyizolowane i oczyszczone szczepy wirusa Chikungunya i sekwencje polinukleotydów i polipeptydów oraz ich zastosowania diagnostyczne i immunogeniczne

Country Status (12)

Country Link
US (2) US20100055105A1 (https=)
EP (2) EP2460822A3 (https=)
JP (2) JP5923232B2 (https=)
AU (1) AU2007226231B2 (https=)
CA (2) CA2545597A1 (https=)
DK (1) DK2001900T3 (https=)
ES (1) ES2543839T3 (https=)
HU (1) HUE025076T2 (https=)
PL (1) PL2001900T3 (https=)
PT (1) PT2001900E (https=)
SI (1) SI2001900T1 (https=)
WO (1) WO2007105111A2 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2545597A1 (en) * 2006-03-15 2007-09-15 Institut Pasteur Novel isolated and purified strains of chikungunya virus and polynucleotides and polypeptides sequences, diagnostic and immunogenical uses thereof
CN101516395B (zh) * 2006-09-01 2014-03-26 伯哈拉特生物技术国际有限公司 抗屈曲病毒感染的疫苗
CA2598966A1 (en) * 2007-09-07 2009-03-07 Institut Pasteur Anti-chikungunya monoclonal antibodies and uses thereof
FR2921064A1 (fr) * 2007-09-14 2009-03-20 Biomerieux Sa Oligonucleotides, utilisation, methode de detection et kit permettant de diagnostiquer la presence du gene e1 du virus du chikungunya
CA2720166A1 (en) * 2008-04-04 2009-10-08 David B. Weiner Consensus sequences of chikungunya viral proteins, nucleic acid molecules encoding the same, and compositions and methods for using the same
EP3957754B1 (en) * 2008-04-21 2026-01-28 Gen-Probe Incorporated Method for detecting chikungunya virus
CN102414217A (zh) * 2009-02-25 2012-04-11 彼格泰格私人有限公司 用于检测基孔肯雅病毒的探针和引物
WO2012078116A1 (en) * 2010-12-10 2012-06-14 Agency For Science, Technology And Research Immunogenic chikungunya virus peptides
WO2012131580A1 (en) * 2011-03-28 2012-10-04 Scms, Institute Of Bioscience And Biotechnology Research And Development Method of detecting chikungunya virus utilizing a recombinant el coat peptide antigen
EP2712871A1 (en) * 2012-09-27 2014-04-02 Institut Pasteur Recombinant Measles virus expressing Chikungunya virus polypeptides and their applications
BR112015006840A2 (pt) * 2012-09-27 2017-11-21 Res Found Dev vírus chikungunya atenuado
JP6903120B2 (ja) * 2016-07-15 2021-07-14 エトゥビクス コーポレーション アルファウイルスワクチン接種のための組成物及び方法
TW202300515A (zh) 2016-10-20 2023-01-01 法商賽諾菲公司 抗ｃｈｉｋｖ抗體及其用途
JP7301811B2 (ja) * 2017-09-21 2023-07-03 ヴァルネヴァ エスイー 免疫原性チクングニアウイルスｃｈｉｋｖ－ｄｅｌｔａ ５ｎｓｐ３を含む医薬組成物を製造する方法
WO2020069054A1 (en) * 2018-09-27 2020-04-02 Texas Tech University System Stable cell line secreting chikungunya virus (chikv) virus like particles (vlp) for vaccines
US20230398200A1 (en) * 2020-07-31 2023-12-14 Replicate Bioscience, Inc. Modified chikungunya viruses and sindbis viruses and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100233209A1 (en) * 2005-08-11 2010-09-16 Higgs Stephen T Chikungunya virus infectious clones and uses therefor
CA2545597A1 (en) * 2006-03-15 2007-09-15 Institut Pasteur Novel isolated and purified strains of chikungunya virus and polynucleotides and polypeptides sequences, diagnostic and immunogenical uses thereof
CN101516395B (zh) * 2006-09-01 2014-03-26 伯哈拉特生物技术国际有限公司 抗屈曲病毒感染的疫苗

Also Published As

Publication number Publication date
US9442114B2 (en) 2016-09-13
PT2001900E (pt) 2015-09-15
WO2007105111A2 (en) 2007-09-20
DK2001900T3 (en) 2015-07-27
EP2460822A3 (en) 2012-09-26
US20150111197A1 (en) 2015-04-23
EP2460822A2 (en) 2012-06-06
CA2646520A1 (en) 2007-09-20
HUE025076T2 (en) 2016-02-29
EP2001900B1 (en) 2015-04-29
JP2013126414A (ja) 2013-06-27
JP6104584B2 (ja) 2017-03-29
JP2009529868A (ja) 2009-08-27
SI2001900T1 (sl) 2015-09-30
CA2545597A1 (en) 2007-09-15
CA2646520C (en) 2018-05-15
AU2007226231B2 (en) 2013-07-11
JP5923232B2 (ja) 2016-05-24
AU2007226231A1 (en) 2007-09-20
WO2007105111A3 (en) 2008-03-27
ES2543839T3 (es) 2015-08-24
EP2001900A2 (en) 2008-12-17
US20100055105A1 (en) 2010-03-04

Similar Documents

Publication Publication Date Title
PL2001900T3 (pl) Nowe wyizolowane i oczyszczone szczepy wirusa Chikungunya i sekwencje polinukleotydów i polipeptydów oraz ich zastosowania diagnostyczne i immunogeniczne
ATE534660T1 (de) Peptidsequenzen und zusammensetzungen
BRPI0817265A2 (pt) Vacina de rna, uso de pelo menos uma molécula de rna, e, molécula de rna isolada
BRPI0719937A2 (pt) Pró-fármacos e métodos de fazer e de usar os mesmos
EP2032180A4 (en) GLUCANZUBEREITUNGEN
EP2277890A4 (en) TO EXTEND THE HALF TIME OF A PEPTIDE OF INTEREST IN A PLASMA PEPTIDE
ATE538137T1 (de) Antikörper gegen menschliches il-22 und verwendungen davon
PT2531206T (pt) Polipéptidos clorotoxina e conjugados e usos dos mesmos
BRPI0715396A2 (pt) Vacinas de matriz proteíca e processos de produção e de administração de tais vacinas
BRPI0813000A2 (pt) Composições terapêuticas e uso das mesmas
EP2029774A4 (en) PROOF OF NUCLEIC ACIDS
EP2399948A4 (en) CATIONIC POLY (AMINO ACIDS) AND USES THEREOF
BRPI0920222A2 (pt) composições catalisadoras e métodos de produção e uso das mesmas
IL226771A0 (en) Recombinant elastase protein, the methods for its production and its use
EP2300038A4 (en) IMPROVED PEPTIDE MEDIATORS OF CHOLESTERINEFFLUX
NO20083139L (no) Anvendelse av hyllebærekstrakt
IL199780A0 (en) Alpha-beta sialon ceramic armor and methods of producing the same
BRPI0717223A2 (pt) polipeptÍdeos hÍbridos imunogÊnicos antiobesidade e composiÇço de vacina antiobesidade compreendendo os mesmos
EP2062046A4 (en) Detecting nitric oxide
LT2205281T (lt) Baltymo ir polimero konjugatai
PL2026879T3 (pl) Zastosowanie peptydów jako wyszczuplających substancji czynnych
ATE488607T1 (de) Drucklose expansion mittels ir
EP2041321A4 (en) VIRAL INHIBITORY NUCLEOTIDE SEQUENCES AND VACCINES
EP2046815A4 (en) INFLAMMATORY AND ANTIALLERGIC CYCLIC PEPTIDES
FI20065805A0 (fi) Taajuusmuuttajan maasulkusuojaus